Verrica Pharmaceuticals (VRCA) Receivables - Net (2023 - 2025)
Verrica Pharmaceuticals has reported Receivables - Net over the past 3 years, most recently at $5.3 million for Q4 2025.
- Quarterly results put Receivables - Net at $5.3 million for Q4 2025, up 10941.67% from a year ago — trailing twelve months through Dec 2025 was $5.3 million (up 10941.67% YoY), and the annual figure for FY2025 was $5.3 million, up 10941.67%.
- Receivables - Net for Q4 2025 was $5.3 million at Verrica Pharmaceuticals, down from $7.0 million in the prior quarter.
- Over the last five years, Receivables - Net for VRCA hit a ceiling of $10.0 million in Q2 2024 and a floor of $48000.0 in Q4 2024.
- Median Receivables - Net over the past 3 years was $5.6 million (2025), compared with a mean of $5.8 million.
- Biggest five-year swings in Receivables - Net: tumbled 98.87% in 2024 and later surged 10941.67% in 2025.
- Verrica Pharmaceuticals' Receivables - Net stood at $4.2 million in 2023, then tumbled by 98.87% to $48000.0 in 2024, then surged by 10941.67% to $5.3 million in 2025.
- The last three reported values for Receivables - Net were $5.3 million (Q4 2025), $7.0 million (Q3 2025), and $9.2 million (Q2 2025) per Business Quant data.